Avid Bioservices Valuation

CDMO Stock  USD 6.68  0.27  4.21%   
At this time, the firm appears to be undervalued. Avid Bioservices shows a prevailing Real Value of $9.63 per share. The current price of the firm is $6.68. Our model approximates the value of Avid Bioservices from analyzing the firm fundamentals such as Current Valuation of 570.64 M, profit margin of (0.08) %, and Return On Equity of -0.0628 as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor obtaining undervalued instruments and abandoning overvalued instruments since, at some point, asset prices and their ongoing real values will blend. Key fundamental drivers impacting Avid Bioservices' valuation include:
Price Book
2.324
Enterprise Value
570.6 M
Enterprise Value Ebitda
978.0362
Price Sales
3.0243
Forward PE
88.4956
Undervalued
Today
6.68
Please note that Avid Bioservices' price fluctuation is slightly risky at this time. Calculation of the real value of Avid Bioservices is based on 3 months time horizon. Increasing Avid Bioservices' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Avid Bioservices is useful when determining the fair value of the Avid stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Avid Bioservices. Since Avid Bioservices is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Avid Stock. However, Avid Bioservices' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  6.68 Real  9.63 Target  19.25 Hype  6.61
The real value of Avid Stock, also known as its intrinsic value, is the underlying worth of Avid Bioservices Company, which is reflected in its stock price. It is based on Avid Bioservices' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Avid Bioservices' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Avid Bioservices' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
9.63
Real Value
15.82
Upside
Estimating the potential upside or downside of Avid Bioservices helps investors to forecast how Avid stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Avid Bioservices more accurately as focusing exclusively on Avid Bioservices' fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
-0.07-0.0025-0.06
Details
Hype
Prediction
LowEstimatedHigh
0.426.6112.80
Details
5 Analysts
Consensus
LowTarget PriceHigh
17.5219.2521.37
Details
Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Avid Bioservices' intrinsic value based on its ongoing forecasts of Avid Bioservices' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Avid Bioservices' closest peers. When choosing an evaluation method for Avid Bioservices, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.

Avid Bioservices Investments

(66.38 Million)

Avid Valuation Trend

Knowing Avid Bioservices' actual value is paramount for traders to make sound investment determinations. Avid Bioservices' real value is not only important for the investor to make better decisions but also for a more accurate overall view of Avid Bioservices' financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Avid Bioservices' enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.

Avid Market Cap

Avid Bioservices is rated below average in market capitalization category among related companies. Market capitalization of Health Care industry is currently estimated at about 39.53 Billion. Avid Bioservices claims roughly 405.36 Million in market capitalization contributing just under 2% to equities under Health Care industry.
Capitalization  Revenue  Total debt  Valuation  Workforce

Avid Bioservices Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Avid Bioservices's current stock value. Our valuation model uses many indicators to compare Avid Bioservices value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Avid Bioservices competition to find correlations between indicators driving Avid Bioservices's intrinsic value. More Info.
Avid Bioservices is rated third in price to earning category among related companies. It is rated below average in price to book category among related companies fabricating about  0.22  of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Avid Bioservices is roughly  4.63 . As of the 24th of April 2024, Price To Book Ratio is likely to grow to 5.34. Comparative valuation analysis is a catch-all model that can be used if you cannot value Avid Bioservices by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Avid Bioservices' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Avid Bioservices' earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Avid Bioservices' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Avid Bioservices and how it compares across the competition.

About Avid Bioservices Valuation

The stock valuation mechanism determines the current worth of Avid Bioservices on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Avid Bioservices. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Avid Bioservices based exclusively on its fundamental and basic technical indicators. By analyzing Avid Bioservices's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Avid Bioservices's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Avid Bioservices. We calculate exposure to Avid Bioservices's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Avid Bioservices's related companies.
Last ReportedProjected for Next Year
Gross Profit36.2 M38 M
Pretax Profit Margin 0.01  0.01 
Operating Profit Margin(0.02)(0.02)
Net Profit Margin 0  0 
Gross Profit Margin 0.24  0.47 

8 Steps to conduct Avid Bioservices' Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Avid Bioservices' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Avid Bioservices' valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Avid Bioservices' financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Avid Bioservices' revenue streams: Identify Avid Bioservices' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Avid Bioservices' industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Avid Bioservices' growth potential: Evaluate Avid Bioservices' management, business model, and growth potential.
  • Determine Avid Bioservices' financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Avid Bioservices' estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Avid Bioservices Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Avid Bioservices does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding63.8 M
Quarterly Earnings Growth Y O Y-0.797
Forward Price Earnings88.4956

Avid Bioservices Current Valuation Indicators

Valuation refers to the process of determining the present value of Avid Bioservices and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Avid we look at many different elements of the entity such as Avid's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Avid Bioservices' valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Avid Bioservices' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Avid Bioservices, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Avid Bioservices' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Avid Bioservices' worth.
When determining whether Avid Bioservices offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Avid Bioservices' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Avid Bioservices Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Avid Bioservices Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avid Bioservices. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
To learn how to invest in Avid Stock, please use our How to Invest in Avid Bioservices guide.
You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Complementary Tools for Avid Stock analysis

When running Avid Bioservices' price analysis, check to measure Avid Bioservices' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avid Bioservices is operating at the current time. Most of Avid Bioservices' value examination focuses on studying past and present price action to predict the probability of Avid Bioservices' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avid Bioservices' price. Additionally, you may evaluate how the addition of Avid Bioservices to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
CEOs Directory
Screen CEOs from public companies around the world
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Transaction History
View history of all your transactions and understand their impact on performance
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Is Avid Bioservices' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avid Bioservices. If investors know Avid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avid Bioservices listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.80)
Earnings Share
(0.18)
Revenue Per Share
2.246
Quarterly Revenue Growth
(0.27)
Return On Assets
(0.01)
The market value of Avid Bioservices is measured differently than its book value, which is the value of Avid that is recorded on the company's balance sheet. Investors also form their own opinion of Avid Bioservices' value that differs from its market value or its book value, called intrinsic value, which is Avid Bioservices' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avid Bioservices' market value can be influenced by many factors that don't directly affect Avid Bioservices' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avid Bioservices' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avid Bioservices is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avid Bioservices' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.